RESUMEN
Integrating photocatalytic oxidation for pollutant removal with hydrogen production via photocatalysis presents a promising approach for sustainable water purification and renewable energy generation, circumventing the sluggish multi-electron transfer inherent in photocatalytic water oxidation. This study introduces novel zero-/one-dimensional (0D/1D) CuWO4/Mn0.3Cd0.7S step-scheme (S-scheme) heterojunctions that exhibit exceptional bifunctional capabilities in photocatalytic degradation and hydrogen production under full-spectrum illumination. The degradation efficiency for tetracycline (TC) using 5 %-CuWO4/Mn0.3Cd0.7S reaches 94.3 % and 94.5 % within 60 min and 6 h, respectively, under ultraviolet-visible (UV-Vis) and near-infrared (NIR) light. Notably, these 0D/1D CuWO4/Mn0.3Cd0.7S S-scheme heterojunctions demonstrate superior hydrogen production, achieving rates of 12442.03 µL g-1h-1 and 2418.54 µL g-1h-1 under UV-Vis light and NIR light irradiation, respectively-these rates are 2.3 times and 55.2 times higher than that of Mn0.3Cd0.7S alone. This performance enhancement is attributed to the intrinsic dimensional effects, transitions of transition metal d-d orbitals, and S-scheme hole/electron (h+/e-) separation characteristics. Additionally, experimental results and density functional theory (DFT) calculations have clarified the modulation of electronic configurations, band alignment, and interfacial interactions via 0D/1D S-scheme heterojunction engineering. This study sheds light on the electron transfer mechanism within S-scheme heterojunction and enhances the effectiveness, economy, and sustainability of recalcitrant pollutant removal and hydrogen production.
RESUMEN
Broadening the absorption region to near-infrared (NIR) light is critical for the photocatalysis due to the larger proportion and stronger penetration of NIR light in solar energy. In the present paper, one-dimensional (1D) MWO4 (M = Mn, Co, and Cd) materials synthesized by electrospinning technique, were studied by combining the density functional theory (DFT) with experiment results, which possessed the enhanced light absorption capability within the range of 200-2000 nm. It was proved that in the ultraviolet-visible (UV-Vis) region, the absorption bands of CoWO4 and MnWO4 samples were attributed to the metal-to-metal charge transfer mechanism, while the absorption of CdWO4 sample may be referable to the ligand-to-metal charge transfer mechanism. In the near-infrared (NIR) region, the absorption of CoWO4 and MnWO4 primarily originated from the d-d orbital transitions of Mn2+ and Co2+. The photocatalytic experimental results showed that the degradation rates for bisphenol A (BPA) over CoWO4, MnWO4, and CdWO4 photocatalysts under UV-Vis/NIR light irradiation for 140 min/12 h were 78.8 %/75.9 %, 23.8 %/21.3 %, 12.8 %/8.7 %, respectively. This research offers the novel insights into the precise construction of tungstate catalytic systems and contributes to the advancement of UV-Vis-NIR full spectrum photocatalytic technology, and lays a foundation for a cleaner and more environmental-friendly future.
RESUMEN
Objective: To compare the effects of intranasal dexmedetomidine (Dex) and oral midazolam in the preoperative medication of children by using a method of meta-analysis. Methods: Cochrane Library, Pubmed, Embase, and Web of Science were searched from inception to July 2023. Randomized controlled trials (RCTs) of intranasal Dex vs. oral midazolam in pediatric premedication were collected. Stata 15.0 statistical software was used to analyze the collected data. Relative risk (RR) and 95% confidence interval (CI) were used as effect sizes. Results: A total of 11 studies with 824 children were included, containing 415 patients in the Dex group and 409 patients in the midazolam group. Compared with the oral midazolam group, the intranasal Dex group had a better preoperative sedation effect at parent-child separation (RR = 1.37, 95% CI: 1.14-1.64) and anesthesia induction (RR = 2.08, 95% CI: 1.03-4.22). In addition, there was no significant difference in the incidence of analgesia remedy (RR = 0.60, 95% CI: 0.36-1.00) the acceptance of anesthesia masks (RR = 0.97, 95% CI: 0.83-1.12), and incidence of adverse events between (RR = 0.25, 95% CI: 0.06-1.13, P = 0.072) between the intranasal Dex and oral midazolam groups. Conclusion: Compared with oral midazolam, intranasal Dex has better sedative effects of parent-child separation and anesthesia induction in pediatric premedication, but there was no difference in the incidence of anesthesia remedy, anesthesia mask acceptance, and incidence of adverse events. Therefore, compared with oral midazolam, intranasal Dex is a better choice for premedication in children.
